Royalty Pharma PLC
(FRA:RPD)
€
24.7
0.58 (2.4%)
Market Cap: 11.36 Bil
Enterprise Value: 15.66 Bil
PE Ratio: 15.19
PB Ratio: 1.87
GF Score: 79/100 - Royalty Pharma PLC at TD Cowen Health Care Conference TranscriptMar 05, 2024
- Q4 2023 Royalty Pharma PLC Earnings Call TranscriptFeb 15, 2024€27.51 (+2.69%)Earnings
- Royalty Pharma PLC at JPMorgan Healthcare Conference TranscriptJan 09, 2024
- Royalty Pharma PLC at Evercore ISI HealthCONx Conference TranscriptNov 28, 2023
- Q3 2023 Royalty Pharma PLC Earnings Call TranscriptNov 08, 2023€24.66 (-3.03%)Earnings
- Royalty Pharma PLC With PTC Therapeutics Inc To Acquire Additional Royalties On Roches Evrysdi Call TranscriptOct 19, 2023
- Royalty Pharma PLC at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Royalty Pharma PLC at Citi BioPharma Conference TranscriptSep 06, 2023
- Q2 2023 Royalty Pharma PLC Earnings Call TranscriptAug 08, 2023€26.98 (-3.64%)Earnings
- Royalty Pharma PLC at Goldman Sachs Healthcare Conference TranscriptJun 13, 2023
- Royalty Pharma PLC at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Royalty Pharma PLC Earnings Call TranscriptMay 09, 2023€31.54 (+0.13%)Earnings
- Royalty Pharma PLC at Cowen Health Care Conference TranscriptMar 07, 2023
- Royalty Pharma PLC at SVB Securities Global Biopharma Conference (Virtual) TranscriptFeb 16, 2023
- Q4 2022 Royalty Pharma PLC Earnings Call TranscriptFeb 15, 2023€35.07 (-0.38%)Earnings
- Royalty Pharma PLC at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Royalty Pharma PLC at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 30, 2022
- Q3 2022 Royalty Pharma PLC Earnings Call TranscriptNov 08, 2022€42.52 (+2.33%)Earnings
- Royalty Pharma PLC at Bank of America Merrill Lynch Global Healthcare Conference TranscriptSep 15, 2022
- Royalty Pharma PLC at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Royalty Pharma PLC at Citi BioPharma Conference TranscriptSep 08, 2022
- Q2 2022 Royalty Pharma PLC Earnings Call TranscriptAug 04, 2022€41.46 (-0.81%)Earnings
- Royalty Pharma PLC at Goldman Sachs Global Healthcare Conference TranscriptJun 14, 2022
- Royalty Pharma PLC at UBS Global Healthcare Conference TranscriptMay 24, 2022
- Royalty Pharma PLC To Host Inaugural Investor Day TranscriptMay 17, 2022
- Q1 2022 Royalty Pharma PLC Earnings Call TranscriptMay 05, 2022€39.48 (-1.48%)Earnings
- Royalty Pharma PLC at Cowen Health Care Conference (Virtual) TranscriptMar 08, 2022
- Q4 2021 Royalty Pharma PLC Earnings Call TranscriptFeb 15, 2022€35.2 (+1.15%)Earnings
- Royalty Pharma PLC at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Cytokinetics Inc and Royalty Pharma Funding Agreements Call TranscriptJan 07, 2022
- Royalty Pharma PLC at Evercore ISI HealthCONx Virtual Conference TranscriptDec 02, 2021
- Q3 2021 Royalty Pharma PLC Earnings Call TranscriptNov 10, 2021€35.4 (+4.73%)Earnings
- Royalty Pharma PLC at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
- Royalty Pharma PLC at Citi BioPharma Conference (Virtual) TranscriptSep 09, 2021
- Q2 2021 Royalty Pharma PLC Earnings Call TranscriptAug 11, 2021€30.8 (-1.91%)Earnings
- Royalty Pharma PLC at Bank of America NAPA Healthcare Conference TranscriptJun 15, 2021
- Royalty Pharma Plc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2021
- Royalty Pharma plc MorphoSys Transaction Conference Call TranscriptJun 02, 2021
- Royalty Pharma PLC at UBS Global Healthcare Virtual Conference TranscriptMay 24, 2021
- Royalty Pharma PLC at Truist Securities Life Sciences Summit (Virtual) TranscriptMay 20, 2021
- Royalty Pharma PLC at Bank of America Global Healthcare Conference (Virtual) TranscriptMay 12, 2021
- Q1 2021 Royalty Pharma Plc Earnings Call TranscriptMay 11, 2021€33.4 (+0.60%)Earnings
- Royalty Pharma PLC at Cowen Healthcare Conference (Virtual) TranscriptMar 02, 2021
- Q4 2020 Royalty Pharma PLC Earnings Call TranscriptFeb 17, 2021€38.6 (-1.53%)Earnings
- Royalty Pharma PLC at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Royalty Pharma PLC at Evercore ISI HealthCONx Conference (Virtual) TranscriptDec 02, 2020
- Q3 2020 Royalty Pharma PLC Earnings Call TranscriptNov 11, 2020€35.8 (+6.55%)Earnings
- Q2 2020 Royalty Pharma PLC Earnings Call TranscriptAug 12, 2020Earnings
- PTC Therapeutics Inc To Monetize Portion of Risdiplam Royalty Stream For $650 Million From Royalty Pharma PLC Call TranscriptJul 20, 2020
Royalty Pharma PLC at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 10, 2022 / 01:15PM GMT
Release Date Price:
€36.4
(+5.20%)
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst
Good morning, everybody. I'm Chris Schott at JPMorgan, and it's my pleasure to be introducing Royalty Pharma at the 40th Annual JPMorgan Conference this morning. We think Royalty Pharma is a really unique business that's helping to finance a lot of the innovation we're seeing occurring across the biopharma space. And from the company, we have Pablo Legorreta, the company's founder and CEO, and we have a broader set of the management team come on for the Q&A. So Pablo, a happy New Year and look forward to the presentation and the Q&A. Over to you.
Pablo Gerardo Legorreta
Royalty Pharma plc - Founder, Chairman of the Board & CEO
Thanks, Chris, and I wish you and everyone also a great 2022.
Christopher Thomas Schott
JPMorgan Chase & Co, Research Division - Senior Analyst
Thank you.
Pablo Gerardo Legorreta
Royalty Pharma plc - Founder, Chairman of the Board & CEO
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)